Matthew Streetly has been a consultant haematologist at Guy's and St Thomas' NHS Foundation Trust since 2008. He is the clinical lead for myeloma and plasma cell disorders and a member of the haemato-oncology inpatient attending team. He looks after people staying in hospital with myeloma, lymphoma and leukaemia.
Matthew is a member of the UK myeloma forum guidelines writing group and a special trustee of the British Society of Haematology.
Education and training
- Fellowship of the Royal College of Pathologists
- Membership of the Royal College of Physicians, London
- PhD investigating new compounds in myeloma and myeloma apoptosis, Queen Mary, University of London
- Postgraduate haematology training, Guy's and St Thomas’
- Medicine (BMedSci and BMBS), University of Nottingham
- Clinical trials for new therapies for myeloma
- Myeloma diagnostics and biomarkers
Matthew has published widely on myeloma and related disorders and is an invited speaker at national and international meetings.
- Myeloma and other plasma cell disorders, including amyloidosis, and monoclonal gammopathy of undetermined significance (MGUS)
- Stem cell transplant
Last updated: December 2022